JOHNSON &JOHNSON VACCINE USE WILL CONTINUE IN GUYANA AMID GLOBAL BLOOD CLOT CONCERN

0
179

The United States Centers for Disease Control and Prevention is again recommending other COVID-19 vaccine brands over the Johnson and Johnson jab, which it says is linked to potentially life-threatening blood clots. Nonetheless, Local Health Authorities are adamant that this adverse event is rare and that the administration of the vaccine will continue in Guyana. Temika Rodney has the details in this report.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.